Ameriprise Financial Inc. lowered its stake in shares of Halyard Health Inc (NYSE:HYH) by 17.7% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 207,232 shares of the medical instruments supplier’s stock after selling 44,681 shares during the quarter. Ameriprise Financial Inc. owned 0.44% of Halyard Health worth $9,334,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Amalgamated Bank increased its position in shares of Halyard Health by 1.2% during the 2nd quarter. Amalgamated Bank now owns 6,655 shares of the medical instruments supplier’s stock valued at $261,000 after purchasing an additional 82 shares during the last quarter. Arizona State Retirement System boosted its holdings in Halyard Health by 1.5% during the 2nd quarter. Arizona State Retirement System now owns 19,700 shares of the medical instruments supplier’s stock valued at $774,000 after acquiring an additional 300 shares during the period. ETRADE Capital Management LLC boosted its holdings in Halyard Health by 4.2% during the 2nd quarter. ETRADE Capital Management LLC now owns 9,671 shares of the medical instruments supplier’s stock valued at $380,000 after acquiring an additional 390 shares during the period. The Manufacturers Life Insurance Company boosted its holdings in Halyard Health by 0.6% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 102,917 shares of the medical instruments supplier’s stock valued at $4,042,000 after acquiring an additional 575 shares during the period. Finally, Thrivent Financial For Lutherans boosted its holdings in Halyard Health by 7.3% during the 2nd quarter. Thrivent Financial For Lutherans now owns 9,497 shares of the medical instruments supplier’s stock valued at $373,000 after acquiring an additional 650 shares during the period. 89.71% of the stock is currently owned by hedge funds and other institutional investors.
A number of research firms recently issued reports on HYH. Zacks Investment Research upgraded Halyard Health from a “hold” rating to a “buy” rating and set a $53.00 price objective for the company in a report on Thursday, January 4th. ValuEngine upgraded Halyard Health from a “hold” rating to a “buy” rating in a report on Sunday, December 31st. TheStreet upgraded Halyard Health from a “c+” rating to a “b” rating in a report on Monday, December 4th. Stifel Nicolaus restated a “buy” rating and set a $52.00 price objective on shares of Halyard Health in a report on Friday, November 3rd. Finally, KeyCorp restated a “hold” rating on shares of Halyard Health in a report on Tuesday, October 17th. One equities research analyst has rated the stock with a hold rating and six have issued a buy rating to the stock. Halyard Health has a consensus rating of “Buy” and a consensus target price of $49.00.
Shares of Halyard Health Inc (NYSE:HYH) traded up $0.48 during mid-day trading on Friday, hitting $49.37. The company’s stock had a trading volume of 204,956 shares, compared to its average volume of 232,956. Halyard Health Inc has a twelve month low of $35.24 and a twelve month high of $50.99. The stock has a market cap of $2,289.83, a PE ratio of 41.49, a price-to-earnings-growth ratio of 2.57 and a beta of 1.77. The company has a quick ratio of 1.19, a current ratio of 2.13 and a debt-to-equity ratio of 0.49.
Halyard Health (NYSE:HYH) last issued its earnings results on Wednesday, November 1st. The medical instruments supplier reported $0.60 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.47 by $0.13. Halyard Health had a return on equity of 8.65% and a net margin of 3.52%. The business had revenue of $401.40 million during the quarter, compared to analysts’ expectations of $394.54 million. During the same period in the prior year, the business earned $0.48 EPS. The business’s revenue for the quarter was up 1.0% compared to the same quarter last year. analysts forecast that Halyard Health Inc will post 2.08 EPS for the current fiscal year.
WARNING: “Ameriprise Financial Inc. Lowers Holdings in Halyard Health Inc (NYSE:HYH)” was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this story can be accessed at https://www.dispatchtribunal.com/2018/01/13/halyard-health-inc-hyh-shares-sold-by-ameriprise-financial-inc.html.
About Halyard Health
Halyard Health, Inc is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections.
Receive News & Ratings for Halyard Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halyard Health and related companies with MarketBeat.com's FREE daily email newsletter.